Influence of CYP3A5*3 and ABCB1 C3435T on clinical outcomes and trough plasma concentrations of imatinib in Nigerians with chronic myeloid leukaemia

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2710|41|5|546-551

ISSN: 0269-4727

Source: JOURNAL OF CLINICAL PHARMACY & THERAPEUTICS, Vol.41, Iss.5, 2016-10, pp. : 546-551

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract